Paloma Partners Management CO Eli Lilly & CO Call Options Transaction History

Paloma Partners Management CO

14 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$772.14 - $960.02 $308,856 - $384,008	400 Added 66.67%	1,000 $885,000
Q2 2024 Aug 14, 2024	SELL	$724.87 - $909.04 $77,561 - $97,267	-107 Reduced 15.13%	600 $543,000
Q1 2024 May 15, 2024	SELL	$592.2 - $792.28 $7.22 Million - $9.66 Million	-12,193 Reduced 94.52%	707 $550,000
Q4 2023 Feb 14, 2024	BUY	$525.19 - $619.13 $6.77 Million - $7.99 Million	12,900 New	12,900 $7.52 Million
Q2 2023 Aug 14, 2023	BUY	$350.74 - $468.98 $4.1 Million - $5.49 Million	11,700 New	11,700 $5.49 Million
Q4 2022 Feb 14, 2023	SELL	$321.55 - $374.67 $225,085 - $262,269	-700 Reduced 15.22%	3,900 $1.43 Million
Q3 2022 Nov 14, 2022	SELL	$296.48 - $337.87 $1.19 Million - $1.35 Million	-4,000 Reduced 46.51%	4,600 $1.49 Million
Q2 2022 Aug 15, 2022	SELL	$278.73 - $327.27 $195,111 - $229,089	-700 Reduced 7.53%	8,600 $2.79 Million
Q1 2022 May 16, 2022	BUY	$234.69 - $291.66 $2.16 Million - $2.68 Million	9,200 Added 9200.0%	9,300 $2.66 Million
Q4 2021 Feb 14, 2022	BUY	$224.85 - $279.04 $22,485 - $27,904	100 New	100 $28,000
Q2 2018 Aug 14, 2018	SELL	$75.7 - $86.88 $2.91 Million - $3.34 Million	-38,500 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$74.21 - $87.6 $2.37 Million - $2.8 Million	-32,000 Reduced 45.39%	38,500 $2.98 Million
Q4 2017 Feb 14, 2018	BUY	$81.94 - $87.89 $1.76 Million - $1.89 Million	21,500 Added 43.88%	70,500 $5.96 Million
Q3 2017 Nov 14, 2017	BUY	$77.07 - $85.54 $3.78 Million - $4.19 Million	49,000	49,000 $4.19 Million

4,011

751M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Paloma Partners Management CO, based on Form 13F filings with the SEC.

Stay updated on Paloma Partners Management CO with notifications on news.